The Maharashtra FDA’s directive to blood banks adds a practical layer to patient and donor safety. Blood collection and transfusion depend on trained staff, correctly identified samples, reliable storage temperatures, screening, documentation and a clear response when something goes wrong. A written order matters only when each centre can demonstrate that these steps are being followed.\n\nFor donors, safety includes informed consent, screening for conditions that make donation unsuitable and observation after collection. For patients, traceability means the unit can be linked to testing, storage and transfusion records. Hospitals should also explain who families can contact when there is a suspected reaction or delay.\n\nMumbai Talks will follow implementation through inspections, public notices and patient experience. We will distinguish a regulatory instruction from evidence that every facility has complied.
Maharashtra blood-bank rules put safety and traceability first
